Analyst firms · Raymond James · ALLO

Raymond James ALLO price target and rating history

Allogene Therapeutics Inc. (ALLO) · Health Care

Raymond James rates Allogene Therapeutics Inc. (ALLO) Mkt Perform with a $36 price target, as of its latest action on Aug 10, 2022. It has published 4 rating actions on ALLO since September 2021, including 3 upgrades and 1 downgrade.

Current rating
Mkt Perform
Price target
$36
Median target, all firms
Too few
Actions on ALLO
4

Raymond James price target on ALLO

$40$36$3220222023202420252026
Raymond James price target on ALLO, each point a stated target, September 2021 to September 2021.

Every Raymond James rating on ALLO

How other firms rate ALLO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesBuy$6Apr 10, 2026
Citizens JMPMkt Outperform$5Jan 9, 2026

Questions about Raymond James and ALLO

What is Raymond James's price target for ALLO?
Raymond James's latest stated price target for Allogene Therapeutics Inc. (ALLO) is $36, from its action on Sep 24, 2021.
What is Raymond James's rating on ALLO?
Raymond James rates ALLO Mkt Perform, a neutral rating, as of Aug 10, 2022.
When did Raymond James last change its view on ALLO?
On Aug 10, 2022, Raymond James downgrades to Mkt Perform from Outperform.

More ALLO rating histories

All Raymond James ratingsALLO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.